Bio Inc - Biomedical Plague vs Crystal Saga II
Bio Inc - Biomedical Plague
Bio Inc - Biomedical Plague is a biomedical strategy simulator that is quite similar to Plague Inc in the sense that you get to develop and modify your own pathogen, be it a virus or a bacteria, and your goal is to eventually kill the person you infect. However, unlike Plague Inc where your goal is to wipe out the human race, this game is more modest in nature since it only gives you to opportunity to help the disease, as opposed to the patient, spread throughout the infected person's systems and win against the team of doctors that are working to save him.Since the game is focused on the individual infectee, you can actually see the human body degrade in real-time as you make your pathogen as resilient and as unstoppable as it can be. This actually makes Bio Inc a more gruesome game to play than Plague Inc. That said, if you're looking for a similar game to Plague Inc, this is, without a doubt, the closest game you can find.
Crystal Saga II
Crystal Saga II is the highly anticipated sequel to the popular browser-based MMORPG, Crystal Saga, that's released just last year. The gameplay itself rivals that of its predecessor and even of other current web-based MMOs, but its graphics has seen a huge revamp and has improved by leaps and bounds. This is evident during your adventures as you will be traversing multiple regions, as well as venturing into various dungeons and battlegrounds. In terms of the class choices, there are six classes to choose from in this game, namely: Knight, Ranger, Rogue, Beastmaster, Mage, and Priest. Each class has varying skills, and it’s a must to pick one according to your play style. You can also recruit a pet to fight for you, marry another character, join a guild and many more.With such an immersive gameplay, Crystal Saga II is so much better than the first game, and it's not surprising to see that this game is currently getting traction. So, if you love browser MMOs, this is one game you wouldn't want to miss!
Platforms
Visit Website Visit Website 
